Open

HER2-positive breast cancer (ADEPT)

To evaluate 3-year invasive disease-free survival in patients with stage I HR+ HER2+ breast cancer treated with adjuvant HP plus endocrine therapy.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)
Visits can be combined with regular clinical appointments

Location

North Carolina (Statewide)

What will be asked of you

The study involves blood draws, physical exams, pregnancy testing (if female), receipt of study drugs, questionnaires, Echo or MUGA scans. You will meet with a member of the study team in addition to your oncology care team during your visits.

Incentives

Study medication.

Total length of participation:
About 5 years study treatment, followed by annual follow up for an additional 5 years.

Looking for Specific Volunteers

Able to participate:

You have been diagnosed with HER2 positive breast cancer
You may have received up to 8 weeks of prior hormonal therapy for your breast cancer
You have undergone surgery for your breast cancer within the last 95 days of study entry 4.

Not eligible if:

You have received neoadjuvant or adjuvant chemotherapy for this breast cancer
You are a pregnant, nursing woman, woman of childbearing potential who is unwilling to use birth control, or man who is unwilling to use adequate
You are receiving other investigational agents for this breast cancer

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Clinical Research
cancerclinicaltrials@med.unc.edu
(919) 966-4432

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Lisa Carey
Medicine- Oncology

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Breast)

IRB Number

23-0369

ClinicalTrials.gov

NCT04569747

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.